Hans G. Lilja, MD, PhD

I am an attending research clinical chemist in the Departments of Laboratory Medicine, Surgery (Urology Service), and Medicine (Genitourinary Oncology Service) at Memorial Sloan-Kettering Cancer Center. With my discovery of free PSA and other prostate-related proteins, I am primarily interested in circulating tumor markers that predict the development and progression of prostate cancer, as well as the possibility that these related markers play a key role in the pathogenesis of prostate cancer. I have contributed to over 180 peer-reviewed scientific publications, primarily detailing the relationship of biomarker proteins, prostate physiology, and pathology. I was a tenured professor at Lund University in Sweden until I moved to Memorial Sloan-Kettering Cancer Center, and I still maintain an active relationship with my former laboratory at Lund University.